Join to View Full Profile
456 W 10th AveColumbus, OH 43210
Phone+1 614-292-3800
Fax+1 614-292-1550
Dr. Cataland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samuel Cataland is an endocrinologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 52 years. He specializes in diabetes and lipid metabolism.
Education & Training
Ohio State University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1968 - 1970- Ohio State University HospitalResidency, Internal Medicine, 1968 - 1970
Mount Carmel Health SystemResidency, Internal Medicine, 1967 - 1968
University of Kentucky College of MedicineResidency, Internal Medicine, 1966 - 1967- Mount Carmel Health SystemInternship, Transitional Year, 1965 - 1966
Certifications & Licensure
OH State Medical License 1965 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2015
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 92 citationsCaplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpuraFlora Peyvandi, Marie Scully, J. A. Kremer Hovinga, Paul Knöbl, Spero R. Cataland
Journal of Thrombosis and Haemostasis. 2017-07-01 - 75 citationsThe Semmes–Weinstein Monofilament as a Potential Predictor of Foot Ulceration in Patients With Noninsulin-Dependent DiabetesPablo Olmos, Samuel Cataland, Thomas M. O'Dorisio, Cecilia A. Casey, William L. Smead
The American Journal of the Medical Sciences. 1995-02-01 - 21 citationsMetabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy.Kwame Osei, Thomas M. O'Dorisio, William B. Malarkey, Elson L. Craig, Samuel Cataland
Diabetes. 1989-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
